The Latest in Non-Hodgkin Lymphoma

Antibody has ‘very promising activity’ in rel/ref CTCL

February 15, 2018

Drug appears safe and active in PTCL, CTCL

February 13, 2018

FDG PET can’t replace BM biopsy, study suggests

February 12, 2018

Inhibitor provides clinical improvement in MF

February 12, 2018

Drug may be option for B- and T-cell lymphomas

February 9, 2018

Assay identifies actionable mutations in lymphoid malignancies

February 9, 2018

Favorable results with chidamide in rel/ref NKTCL

February 8, 2018

Combo is preferentially active in T-cell lymphomas

February 7, 2018

Duvelisib combos show promise for PTCL, CTCL

February 7, 2018

FDA investigating VTEs related to ECP

February 6, 2018

Mogamulizumab is ‘valuable’ option for CTCL

February 5, 2018

In situ vaccination eradicates lymphoma, other cancers

February 3, 2018

Combo could treat double-hit lymphoma

February 2, 2018

Technique could aid treatment of CLL

January 25, 2018

EC authorizes brentuximab vedotin for CTCL

January 23, 2018